The U.S. is making progress against one of its most devastating public health threats: drug overdoses. Over the 12 months ending in October 2024, the country saw a 25% decline in overdose deaths ...

The length of time this chemical stays in the body or continues to show in a drug test depends on many factors, including a person’s body composition, cannabis use, and the test’s sensitivity.

Importantly, the chart doesn't illustrate how drug companies themselves benefit from rebates. Take Sanofi, which paid $7.3 billion in "discretionary" rebates last year, to commercial health ...